Healthcare -
Biotechnology - NASDAQ - US
$ 2.78
-0.714 %
$ 58.6 M
Market Cap
-0.63
P/E
OCX - OPERATING EXPENSES
Operating Expenses OCX - OncoCyte Corporation
25.6 M
LAST VALUE
-26.25%
2 YEAR CAGR
11.02%
5 YEAR CAGR
22.05%
10 YEAR CAGR